MEDICLIN Aktiengesellschaft (ETR:MED)

Germany flag Germany · Delayed Price · Currency is EUR
2.980
0.00 (0.00%)
Apr 24, 2025, 12:30 PM CET
4.93%
Market Cap 141.55M
Revenue (ttm) 761.65M
Net Income (ttm) 24.84M
Shares Out 47.50M
EPS (ttm) 0.52
PE Ratio 5.73
Forward PE 4.58
Dividend n/a
Ex-Dividend Date Jun 5, 2025
Volume 1,520
Average Volume 5,618
Open 2.980
Previous Close 2.980
Day's Range 2.980 - 2.980
52-Week Range 2.280 - 3.100
Beta 0.20
RSI 56.99
Earnings Date May 2, 2025

About ETR:MED

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others. The company also provides services in the areas of ENT and acute outpatient services. It owns clinics, rehabilitation care, nursing care fac... [Read more]

Sector Healthcare
Founded 1994
Employees 10,472
Stock Exchange Deutsche Börse Xetra
Ticker Symbol MED
Full Company Profile

Financial Performance

Financial Statements

News

MEDICLIN Celebrates a Successful 2024 Financial Year

In 2024, MEDICLIN AG reached unprecedented financial success, with sales hitting EUR 748.8 million and an operating result of EUR 53.5 million, thanks to strategic growth and key acquisitions. Jetzt d...

27 days ago - Wallstreet:Online

EQS-News: MEDICLIN ends successful 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Annual Report/Miscellaneous MEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CEST The issuer is solely responsible for the content of this annou...

27 days ago - Wallstreet:Online

EQS-News: MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024

EQS-News: MEDICLIN AG / Key word(s): Conference/Miscellaneous MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 19.03.2025 / 15:18 CET/CEST The is...

5 weeks ago - Wallstreet:Online

MEDICLIN Unveils 2024 Financial Year Preliminary Figures

MEDICLIN's 2024 performance reflects strategic growth, with sales rising to EUR 748.8 million and operating results soaring. The company excelled in post-acute care, while strategic investments set th...

2 months ago - Wallstreet:Online

EQS-News: MEDICLIN presents preliminary figures for the 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Preliminary Results MEDICLIN presents preliminary figures for the 2024 financial year 27.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content ...

2 months ago - Wallstreet:Online

MEDICLIN Boosts 2024 Outlook with Raised Guidance

MEDICLIN AG anticipates a prosperous 2024, raising its EBIT forecast to EUR 48-54 million and predicting sales growth of 1-3%, with detailed results due in February 2025. Jetzt den vollständigen Artik...

3 months ago - Wallstreet:Online

EQS-Adhoc: MEDICLIN raises full-year guidance for the 2024 financial year

EQS-Ad-hoc: MEDICLIN AG / Key word(s): Forecast/Annual Results MEDICLIN raises full-year guidance for the 2024 financial year 21-Jan-2025 / 16:36 CET/CEST Disclosure of an inside information acc. to A...

3 months ago - Wallstreet:Online

MEDICLIN Boosts Sales & Profits; 2024 Forecast Confirmed by Management

MEDICLIN has shown robust growth in 2024, with sales climbing by 2.0% and EBIT rising significantly. As the company enhances its services and anticipates hospital reforms, it remains optimistic about ...

6 months ago - Wallstreet:Online

EQS-News: MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024

EQS-News: MEDICLIN AG / Key word(s): 9 Month figures/Miscellaneous MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024 04.11.2024 / 14:30 CE...

6 months ago - Wallstreet:Online